Cargando…
SUN-385 Differential Effects of Abaloparatide and Teriparatide on Hip Cortical Volumetric BMD by DXA-Based 3d Modeling
The osteoanabolic agent abaloparatide (ABL) has been shown to significantly increase total hip BMD over an 18-month period in postmenopausal women with osteoporosis. However, it remains unknown if these gains predominantly occur in the cortical or trabecular compartments of the proximal femur, and h...
Autores principales: | Winzenrieth, Renaud, Ominsky, Michael S, Wang, Yamei, Humbert, Ludovic, Weiss, Richard J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209294/ http://dx.doi.org/10.1210/jendso/bvaa046.255 |
Ejemplares similares
-
Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling
por: Winzenrieth, R., et al.
Publicado: (2021) -
SUN-533 Noninvasive, DXA-Derived Bone Structure Assessment of Acromegaly Patients
por: Kuzma, Martin, et al.
Publicado: (2019) -
SUN-335 Abaloparatide Prevents Unloading-Induced Bone Loss in Adult Rats
por: Teguh, Dian A, et al.
Publicado: (2020) -
OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
por: Lane, Nancy, et al.
Publicado: (2019) -
SUN-383 Potential Impact of Using Male vs Female T-Scores for BMD Classification in Men
por: Fatoki, Raleigh A, et al.
Publicado: (2020)